Insights

News

Artificial intelligence detects first patients with rare neurological disease. Danny Platform enables screening and early diagnosis for high-risk patients

Interview with Prof. Milanov and Prof. Bogdanova, published in Kapital Health, December 2022 Prof. Milanov Prof. Dr. Ivan Milanov, Ph.D., is the Executive Director of...

Read more...

News

First patients diagnosed with rare disease with assist of AI algorithm are a fact

Sqilline and a leading pharmaceutical company have partnered to apply an AI algorithm and track high-risk patients for the rare disease of Transthyretin amyloid polyneuropathy (TTR)....

Read more...

News

Beyond the randomized clinical trials comes the real-world evidence

Sofia, November 14, 2022 – Dr. Gergana Shalamanova from the Oncology Center in Plovdiv showed the interesting comparison of Real-world Evidence (RWE) vs. Randomized Clinical...

Read more...